Top 5 Low Price Stocks To Invest In 2018

&l;p&g;&l;img class=&q;dam-image bloomberg size-large wp-image-41898988&q; src=&q;×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Bloomberg

Warren Buffett&s;s portfolio of stocks at Berkshire Hathaway has always contained a good number of insurance stocks. He likes them, always has.

Omaha&s;s most-famous investor started with his purchase of National Indemnity Company way back in 1967 and has continued since then with famous old names like GEICO and General Re, among many others.

If we imitate his methods, could we find success?

There&s;s no telling, but… one of the first steps in finding value is to see if the stock is trading at a low price/earnings ratio and if it can be purchased at a discount to book value.

Here are four insurance stocks that may fit as the type of value situation sought under the Buffett-like criteria he learned from Benjamin Graham:

&l;strong&g;AEGON N.V.&l;/strong&g; is a life insurance company based in the Netherlands and which trades on the New York Stock Exchange. With a price/earnings ratio of 5.4 and now priced at half its book value, it definitely looks like a value stock. The concern would be debt: There&s;s more of that than equity.

Top 5 Low Price Stocks To Invest In 2018: BioMarin Pharmaceutical Inc.(BMRN)

Advisors’ Opinion:

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Ben Levisohn]

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

  • [By Chris Lange]

    Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is breaking out from a bullish continuation pattern after completing a 2-year+ consolidation bottom. Upside is seen to the $200 area. Celgene Corp. (NASDAQ: CELG), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), and Incyte Corp. (NASDAQ: INCY) have weaker technical patterns and may have further downside risks. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is forming a potential bearish top – a move below $77.98 would open $71 to the $60 area.

  • [By George Budwell, Rich Smith, and Matthew DiLallo]

    With this question in mind, we asked three of our contributors which stocks they recommend to buy and hold for the next 20 years. They suggestedBioMarin Pharmaceutical (NASDAQ:BMRN), Enterprise Products Partners (NYSE:EPD), andLockheed Martin (NYSE:LMT). Below, they discuss why they chose these particular stocks, and why investors with a long-term outlook may want to consider adding them to their portfolios right now.

  • [By Chris Lange]

    BioMarin Pharmaceutical Inc.’s (NASDAQ: BMRN) first-quarter results are due late on Wednesday. The consensus forecast calls for a net loss of $0.18 per share and revenue of $348.57 million. The shares ended last week at $82.30. The consensus analyst target is $114.30. The 52-week trading range is $75.81 to $100.51.

Top 5 Low Price Stocks To Invest In 2018: Panasonic Corporation (PCRFY)

Advisors’ Opinion:


    A Unilever vs. Panasonic (OTCPK:PCRFY) showdown seems to be something out of an alternative, weird universe. But that’s exactly what has been happening in the Asia-Pacific region, where Unilever is now a major seller of air and water purification devices. The acquisitions of Qinyuan and Pureit water purifiers, as well as the acquisition of Sweden-based Blueair in 2016, reflects Unilever’s latest growth strategy of reducing exposure to low-growth brands in favor of greater investments in higher-growth products with strong social and environmental credentials.


    Clean Technica reported on September 1 that “Sony is entering the EV battery manufacturing industry”. And “considering that electric vehicle batteries are going to be the main supply bottleneck for the upcoming auto market’s embrace of EVs, the entry of Sony into the field is very notable. Most of the other manufacturers (Panasonic (OTCPK:PCRFY), LG Chem (OTC:LGCLF), etc.) already have more or less all of their production capacity locked up for the coming years – meaning there’s not much left for the auto manufacturers that are running behind, thereby limiting potential EV sales for the firms in question. Sony’s (NYSE:SNE) entry into the field should open things up a bit more”. Certainly a good move by Sony and helpful for the EV companies that will find themselves in need of batteries, and limited availability, should EVs reach 10% by 2020.

  • [By Ben Levisohn]

    During the early stages of a new innovation, interdependent architectures and integrated companies best optimize performance and functionality. This trend has played out in computing and handsets, and we see the same trend playing out in EVs. We find Tesla and BYD1 , by far, the most vertically integrated players in EVs, with huge scale advantages. In addition, LG Chem, Panasonic (PCRFY), Samsung SDI, BYD, and CATL are clear scale leaders in batteries (CATL is not publicly traded. All but Samsung SDI and BYD are not covered by Bernstein.).


    SMMYY is a subsidiary of the Sumitomo Group. SMMYY is a major smelter and refiner of copper, nickel and gold in Japan, and has a 27.5% stake in the Ambatovy Nickel Project in Madagascar, along with Sherritt International and Korea Resources Corp. Feedstock for the refinery is nickel cobalt mixed sulphide from its Taganito and Coral Bay mines in the Philippines (noting the Philippines is a risky supply source at this time). Sumitomo supply Panasonic (OTCPK:PCRFY) who supply Tesla (NASDAQ:TSLA); however, this can change. Generally, I like the stock; however, at this time, valuation looks full, trading on a 2017 PE of 32.8, and 2018 PE of 14.8. Good to buy after a pullback if that occurs.


    JOLED is a company that was established in 2014 by by Japan Display, Sony (NYSE:SNE) and Panasonic (OTCPK:PCRFY). And they are not the only ones:

    During an OLED display Seminar in Korea, UniJet’s CEO Kim Seok-Soon said that new advances in Ink-Jet printing technologies could enable displays that are over 500 PPI – and so make printing a viable technology to produce small and medium-sized OLED panels.

  • [By ]

    CBAK is in a very competitive industry, as well as being small relative to its competitors. Among the Company’s competitors are giants like Panasonic (OTCPK:PCRFY) and Samsung (OTC:SSNLF), but overall it faces competition from Japan, Korea, and China. Although CBAK states that “we are able to leverage our low-cost advantage to compete favorably with our competitors”, it is hard to see that being the reality, especially when looking at the above gross margins. Still, the Company may enjoy lower labor costs, since it sources labor locally and apparently it has “higher consistency and safety in product quality, which enables us to compete favorably with local competitors”. But given the greater resources of at least some of its competitors and the constantly evolving dynamics of the industry, competition is surely a risk factor to consider.

Top 5 Low Price Stocks To Invest In 2018: Intersil Corporation(ISIL)

Advisors’ Opinion:

  • [By Scott Rubin]

    Big gainers on the day included Intersil Corp (NASDAQ: ISIL), which jumped 20 percent on news of a buyout, and Medivation (NASDAQ: MDVN), which added 20 percent on a deal with Pfizer (NYSE: PFE) related to its cancer drug. Cotiviti Holdings Inc (NYSE: COTV) lost around 9 percent in the wake of a mid-day sell-off and Marathon Oil Corporation (NYSE: MRO) fell 7 percent in the wake of a management shakeup.

Top 5 Low Price Stocks To Invest In 2018: CEVA, Inc.(CEVA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION WARNING: “CEVA (CEVA) Rating Increased to Hold at BidaskClub” was posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at

Top 5 Low Price Stocks To Invest In 2018: Noble Energy Inc.(NBL)

Advisors’ Opinion:

  • [By Paul Ausick]

    Noble Energy Inc. (NYSE: NBL) is rated a Buy and Jefferies raised the price target to $47. The 2017 net loss estimate was lowered from $0.40 per share to $0.22 per share. The 2018 EPS estimate was raised from $0.94 to $1.34. Shares closed at $36.71 on Friday, in a 52-week range of $28.82 to $42.03, and the consensus price target is $48.22.

  • [By Jon C. Ogg]

    Noble Energy Inc. (NYSE: NBL) was raised to Buy from Hold with a $32 price target at Jefferies on December 20. The shares closed up 3.6% at $27.23 on Tuesday, in a 52-week range of $22.99 to $40.89. This call is actually almost $4 lower than the pre-call consensus price target, but Noble shares were up over 1% at $27.52 afterward.


    Noble Energy (NBL) : “Noble’s good. It’s a very well-run, conservative company. It should do well in this environment.”

    Himax Technologies (HIMX) : “That area is so red-hot. I think it’s fine, but I like Cypress Semiconductor (CY) more.”